Company record
CPL, Inc. produces active pharmaceutical ingredients and supplies a comprehensive API portfolio that includes alendronate sodium, amlodipine besylate, hydrochloride, chlorhexidine bases, chlorhexidine gluconate, glyburide, losartan potassium, meloxicam, ondansetron bases, rabeprazole sodium, rupatadine fumarate, sildenafil citrate, telmisartan, valsartan, and zolpidem tartrate.
This directory record does not yet have a linked material-flow brief.